激活物

蛇毒蛋白C激活物的初步研究

A Preliminary Study of Protein C Activator from Venom of Agkistrodon halys pallas

组织型纤溶酶原激活物基因的DNA改组

DNA family shuffling of tissue-type plasminogen activator genes

阿罗洛尔对不稳定型心绞痛患者高敏C反应蛋白和纤溶酶原激活物抑制剂-1含量的影响

Effect of Arotinolol on High-sensitive C-reactive Protein and Plasminogen Activator Inhibitor-1 in Patients with Unstable Angina

蝮蛇毒蛋白C激活物对凝血系统的影响

The action of protein C activator from venom of Agkistrodon halys Pallas on blood coagulant system

血清胆固醇水平与血浆纤维蛋白原水平和纤溶酶原激活物抑制剂-1活性呈显著的正相关性（P＜0.05）。

Serum cholesterol level was also positively correlated with plasma fibrinogen level and PAI-1 activity ( P0.05 ) .

蝮蛇毒蛋白C激活物对内毒素性离体大鼠心脏功能的影响

Effect of protein C activator from Agkistrodon halys pallas venom on endotoxin cardiac function of rat in vitro

蝮蛇毒蛋白C激活物对全脑缺血再灌注损伤大鼠血液粘度变化的影响

Protein C activator from venom of agkistrodon halys on the blood viscosity of rats suffered from total cerebral ischemia-reperfusion injury

广西圆斑蝰蛇毒凝血因子X激活物在实验鼠体内的促凝血作用研究

The hemostasis effect on experimental mice of RVV-X from venom of Viper russellii in Guangxi

目的：研究蝮蛇毒蛋白C激活物组分对败血症大鼠心脏血流动力学的影响。

Objective : To investigate the effect of protein C activator from Agkistrodon halys venom on cardiac hemodynamics in septic shock rats .

葛根素对不稳定心绞痛患者血小板颗粒膜蛋白、溶酶体膜蛋白及血浆纤溶酶原激活物抑制物、C反应蛋白的影响

Effect of Puerarin on Platelet Activating Factors CD63 and CD62P , Plasminogen Activator Inhibitor and C-reactive Protein in Patients with Unstable Angina Pectoris

目的：探讨C反应蛋白对内皮细胞株304细胞释放前列环素、纤溶酶原激活物抑制剂1的影响。

AIM : To investigate the effect of C reactive protein on prostaglandin and plasminogen activator inhibitor-1 in endothelial cell strain 304 cells .

TF-FⅦa复合物影响人卵巢癌细胞尿激酶型纤溶酶原激活物受体mRNA表达的研究

Study of the effect of TF / F ⅶ a complex on the expression of u-PAR mRNA in human ovarian cancer

IgA肾病患者纤溶酶原激活物的变化及临床意义

The changes of plasminogen activators in patients with IgA nephropathy and their clinical significance

纤溶酶原激活物抑制物、组织纤溶酶原激活剂、血栓素B2及6-酮-前列腺素F（1α）对糖尿病视网膜病变早期诊断的临床意义

Clinical significance of plasminogen activator inhibitor , tissue plasminogen activator , thromboxane B_2 and 6-Ketosteroid-prostaglandin F_ ( 1 α) in early diagnosis of diabetic retinopathy

其相关机制主要是AR共激活物DDC的表达受到抑制。

The correlated molecular mechanism was the down-regulation of the androgen receptor coactivator DDC .

目的：了解5／6肾切除大鼠尿纤溶酶原激活物（PA）排泄量的动态变化。

Objective : to observe the urinary plasminogen activator ( PA ) excretion in5 / 6 nephrectomized rats .

方法：采用纤维蛋白原平板溶环法，检测尿中纤溶酶原激活物PA的活性；

Method : Fibrin plate method was applied to examine activity of urinary plasminogen activator ( PA ) .

Ⅰ型纤溶酶原激活物抑制物在IgA肾病肾小管间质损伤中的作用研究

Role of type I plasminogen activator inhibitor in mediating renal tubulointerstitial injury of patients with IgA nephropathy

IgA肾病肾血管纤溶酶原激活物抑制物-1和基质金属蛋白酶-9的表达及其意义

Expressions of alpha-sma , pai-1 , MMP-9 and TIMP-1 in renal vessels of patients with IgA nephropathy

可溶性尿激酶型纤溶酶原激活物受体在RA患者血浆和滑液的水平及其临床意义

Detection and significance of soluble urokinase-type plasminogen activator receptor in plasma and synovial fluid of patients with rheumatoid arthritis

目的：探讨IgA肾病患者纤溶酶原激活物（PA）的变化及临床意义。

Purpose To find out the changes of plasminogen activators ( PA ) in IgA and their clinical significance .

纤溶酶原激活物抑制剂1（PAI-1）是一种重要促凝血因子。

Plasminogen activator inhibitor 1 ( PAI-1 ) is one of important coagulant factors .

酶谱分析法检测其纤溶酶原激活物（tPA）活性。

Zymography analysis for determining the activity of tissue type plasminogen activators ( tPA ) .

SQ复方能降低纤溶酶原激活物（t-PA）的含量。

SQ complex prescription decreased the contends of tissue plasminogenactivator ( t-PA ) .

联合转染反义c-myc寡核苷酸和组织纤溶酶原激活物基因预防损伤后动脉内膜增生的研究

Co-transfection of tPA gene and c-myc antisense oligodeoxynucleotides for the prevention of intimal hyperplasia of rabbit auto-transplantion artery

NIDDM病人血浆组织型纤溶酶原激活物及其抑制物的活性水平与胰岛素抵抗关系的探讨

The Relationship of Tissue Plasminogen Activator and Inhibitor Activity Levels with Insulin Resistance in NIDDM Patient

多重线性回归分析显示三酰甘油、总胆固醇、空腹血糖、收缩压、舒张压，与纤溶酶原激活物抑制物1活性呈显著正相关（P均<0.01）。

Multiple linear regression analysis revealed that the plasma PAI-1 levels were positively correlated with TG , TC , fasting blood glucose , systolic blood pressure and diastolic blood pressure ( all P < 0.01 ) .

肝X受体激动剂对高脂载脂蛋白E基因缺陷小鼠动脉壁一氧化氮合酶、增殖细胞核抗原和纤溶酶原激活物抑制剂1表达的影响

The Effects of Liver X Receptor Agonists on the Expressions of Nitric Oxide Synthase , Proliferating Cell Nuclear Antigen and Plasminogen Activator Inhibitor-1 in the Artery of Apolipoprotein E-Deficient Mice

目的：尿酸与纤溶酶原激活物抑制剂-1（PAI-1）之间的关系仍不清楚。

Objiect : The relation between uric acid and tissue plasminogen inhibitor-1 ( PAI-1 ) remains unclear .

治疗后进一步上调有3个点：谷胱甘肽S-转移酶P（23293/7.30），组织型纤溶酶原激活物前体（62862/8.55），抗氧化蛋白2（24439/5.8）。

After the treatment further up-regulated had 3 spots : Glutathione S-transferase P ( 23 293 / 7.30 ), tissue-type plasminogen activator precursor ( 62 862 / 8.55 ), anti-oxidant protein 2 ( 24 439 / 5.8 ) .